Preliminary study assesses durability of NAb titers against Omicron after mRNA-1273 booster
Researchers from Moderna, the developers of one key vaccine, have been investigating its ability to protect against the Omicron variant.
Serum Neutralizing Activity Image Credit For Panels Coronavirus Disease Covid 19 Immune System Ars Cov 2
Source: news-medical.net